Table 1 Characteristics of subjects recruited.

From: S-maltoheptaose targets syndecan-bound effectors to reduce smoking-related neutrophilic inflammation

 

Non-COPD Controls

COPD patients

P values

Number of subjects

14

28

 

Male Gender

14

28

 

Age (years)

62.4 ± 9.3

73.1 ± 5.5

P = 0.065

Smoking status

Current smokers

6

20

 

Ex-smokers

2

8

 

Non-smokers

6

0

 

FEV1% predicted

88.6 ± 10.0

62.4 ± 15.6

P < 0.01

FEV1/FVC

75.5 ± 3.7

52.5 ± 13.4

P < 0.01

  1. Data are presented as mean ± SD. COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume in one second; FVC: forced vital capacity.